Skip to content

Evaluation of the Efficacy and Mechanisms of a Novel Intervention for Chronic Pain Tailored to People Living With HIV

CompletedNot applicableNCT03692611
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Due to its prevalence and impact on quality of life and overall health, the National Academy of Medicine has called chronic pain a "public health crisis." Therefore, this proposal is relevant to public health because it seeks to improve chronic pain treatment in accordance with the approach recommended by the Department of Health and Human Services National Pain Strategy: to develop and test Pain Self-Management interventions tailored to the needs of vulnerable populations, particularly people living with HIV (PLWH). Chronic pain is an important and understudied comorbidity among PLWH; therefore, this proposal is responsive to the NIH's HIV Research Priorities, which identify comorbidities as a high priority research topic.

Study details

Official title
Evaluation of the Efficacy and Mechanisms of a Novel Intervention for Chronic Pain Tailored to People Living With HIV
Conditions
Interventions
  • Behavioral: Skills TO Manage Pain (STOMP)
  • Behavioral: Comparison group
Sponsor
University of Pittsburgh
Collaborators
University of Alabama at Birmingham; National Institute of Mental Health (NIMH); University of North Carolina, Chapel Hill
Start date
2019-08-14
Primary completion
2024-01-14
Sex
All
Age range
from 18 Years to 89 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Enrolled in CNICS 2. Age ≥ 18 years 3. English-speaking 4. Chronic pain (Brief Chronic Pain Screening Questionnaire (BCPQ) = at least moderate pain for at least 3 months) 5. Moderately severe and impairing chronic pain (PEG pain questionnaire = average of all three items is 4 or greater) 6. Ability and willingness to attend the group sessions at the date/time specified 7. No plans for major surgery during the study period that would interfere with study procedures. Exclusion Criteria: 1. Do not speak or understand English 2. Are planning a new pain treatment like surgery 3. Cannot attend the group sessions 4. Had previously participated in the pilot study (STOMP) 5. Unwilling to provide informed consent

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03692611